We are excited to announce that Andreas Pircher has joined our team as the new Key Account Manager. His wealth of experience will be invaluable as we continue our journey toward greater success. Looking forward to achieving great things together. Welcome, Andreas! #angelinipharma
Angelini Pharma Switzerland
Arzneimittelherstellung
Driven to bring new solutions to people suffering from Epilepsy and diseases affecting Brain Health
Info
We are Angelini Pharma Switzerland, the pharmaceutical division of Angelini Industries and formerly Arvelle Therapeutics International GmbH. The company started more than100 years ago as a local pharmaceutical laboratory. Angelini Pharma is the pharmaceutical division of Angelini Industries that has grown through the years into a leading international company present in pharmaceuticals and the mass-market. Angelini Pharma is a leader in healthcare with particular expertise in Brain Health focusing in the fields of Mental Health and Epilepsy. The company is also a leading player in the Consumer Health segment with highly successful OTC brands marketed worldwide. Angelini Pharma operates directly in 20 countries, employing almost 3,000 people and commercialises its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups. In Switzerland the commercial organization operates with its branch located in Zug, Angelini Pharma Zug S.p.A. and employs approximately 15 people at its headquarters. The dedication of the team is driven by passion to improve the lives of patients who are affected by Epilepsy and diseases that impact Brain Health. Angelini Pharma was awarded and recognized as the best employer in Europe for the third consecutive year for the development and well-being of their employees guaranteeing the best working conditions. The company continues to research, develop, and commercialize health solutions that impact Brain Health. The research embraces public-private partnerships with recognized academic institutions and centers of global importance. The Scientific Network and our Partnerships in Switzerland both have an important role in creating innovation within the topical anti-inflammatory, anti-depressant, and pain management sectors. Contact us to find out more about our company and leadership team located in Zug at [email protected] or 41 (0) 417115882
- Website
-
https://www.angelinipharma.ch/en/
Externer Link zu Angelini Pharma Switzerland
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zug
- Art
- Privatunternehmen
- Gegründet
- 2021
- Spezialgebiete
- Pharmaceuticals, Epilepsy, brain health, focal onset seizures, CNS, Depression, Pain Management, Anti-inflammation, Seizure freedom, Healthcare, Consumer Health und OTC
Orte
-
Primär
Wegbeschreibung
Zählerweg 6
Zug, 6301, CH
Beschäftigte von Angelini Pharma Switzerland
Updates
-
🚀 Welcoming Nikolaos Grigoropoulos as our new QA Manager for Angelini Switzerland marks another milestone in our journey. Thrilled to have him on board as we continue to reach new heights together! Welcome, Nikolaos! #angelinipharma
-
-
We are looking for you! Join us in Switzerland: https://lnkd.in/dZrUM7uU
-
-
Angelini Pharma Switzerland hat dies direkt geteilt
Prof. Paul Boon words at our recent international event "From Now On" held in Milan a few weeks ago, where we shed light on the critical role of early action in preserving neurological health for more fulfilling lives. Together, we promote understanding and support for brain health. #AngeliniPharma #EveryStepCloser #WithYouInMind
-
-
Exciting news! The Swiss Brain Health Plan launches in Switzerland. The goal of the plan is to raise awareness of brain health as a whole, launch prevention and education programs. The Federation of Clinical Neuro-Societies SFCNS is initiating the plan in response to the EAN brain health strategy launched by the WHO and EAN in 2022. #brainhealth #epilepsy #everystepcloser
-
Angelini Pharma Switzerland hat dies direkt geteilt
His story radiates passion, dedication, and a profound love for diversity, emphasizing the importance of a patient-centric vision and a commitment to making a real impact on people's lives. In this new episode of the "Nice to Meet You" podcast, we delve into the journey of Erik Lommerde, our International Chief Commercial Operations Officer. 👉 https://lnkd.in/dgmsYuAf #AngeliniPharma #EveryStepCloser #WinAsOne #NiceToMeetYou
-
Angelini Pharma Switzerland hat dies direkt geteilt
Last week we held our quarterly global townhall from our pharmaceutical plant in Ancona, Italy, a key site in our network https://lnkd.in/dVdWybU4, a way to celebrate and recognize the resilience and commitment of our colleagues in manufacturing, quality, engineering and supply chain across all our Tech Ops organization. Our teams have made in the years under the leadership of Enrico Giaquinto substantial progress in quality, customer service, digital applications to product cycle and sustainability. Ancona is also a special place for all of us, where Angelini Pharma was born more than 100 years ago, a place where our local colleagues feel like at home and develop a deep sense of belonging. Check out the video and listen to the voices of our Tech Ops colleagues as we keep building our future with the passion and energy needed to achieve the greatest goal of improving people's health.
-
Angelini Pharma Switzerland hat dies direkt geteilt
Persons living with mental health conditions can face significant disadvantages at work. Discrimination, unequal pay, and reduced responsibilities can make mental health problems worse. With “Headway - Mental Health Index 3.0” we are making strides in understanding the interaction between work and mental well-being. We are promoting open dialogue and driving change. Together, we can make a significant impact! 👉 https://lnkd.in/dM8Jedth #AngeliniPharma #EveryStepCloser #WithYouInMind #Headway2023